Ucb SA logo

UCB - Ucb SA News Story

€80.94 -0.1  -0.1%

Last Trade - 09/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £13.28bn
Enterprise Value £14.23bn
Revenue £4.64bn
Position in Universe 58th / 848

BUZZ-UCB: Jumps after 'reassuring' outlook

Thu 25th February, 2021 8:49am
** Shares in UCB  UCB.BR  jump 7% and top Belgium's
blue-chip BEL20 index  .BFX  after the biopharmaceutical company
posts "reassuring" 2021 and 2025 guidance 
    ** The group said it expects its 2021 revenue to reach
between 5.45 and 5.65 billion euros, with an adjusted EBITDA
representing 27-28% of revenue  urn:newsml:reuters.com:*:nASN000VKR
    ** For 2025, UCB expects the revenue of at least 6 billion
euros and sees adjusted EBITDA margin in low to mid-thirties
    ** "Overall, we see the 2021 outlook and provision of 2025
guidance reassuring the market, and hence would expect the
shares outperform by 2-3% today," JP Morgan says
    ** Jefferies says 2020 results are broadly in-line but EPS
beat and new outlooks suggest EPS upgrades
    ** "New 2025 aims are bullish," says the broker
    ** KBC Securities echoes these comments, adding that "short
and mid-term guidance show confidence"

 ((anait.miridzhanian@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.